Literature DB >> 17572227

Muscarinic and alpha 1-adrenergic receptor binding characteristics of saw palmetto extract in rat lower urinary tract.

Mayumi Suzuki1, Tomomi Oki, Tomomi Sugiyama, Keizo Umegaki, Shinya Uchida, Shizuo Yamada.   

Abstract

OBJECTIVES: To elucidate the in vitro and ex vivo effects of saw palmetto extract (SPE) on autonomic receptors in the rat lower urinary tract.
METHODS: The in vitro binding affinities for alpha 1-adrenergic, muscarinic, and purinergic receptors in the rat prostate and bladder were measured by radioligand binding assays. Rats received vehicle or SPE (0.6 to 60 mg/kg/day) orally for 4 weeks, and alpha 1-adrenergic and muscarinic receptor binding in tissues of these rats were measured.
RESULTS: Saw palmetto extract inhibited specific binding of [3H]prazosin and [N-methyl-3H]scopolamine methyl chloride (NMS) but not alpha, beta-methylene adenosine triphosphate [2,8-(3)H]tetrasodium salt in the rat prostate and bladder. The binding activity of SPE for muscarinic receptors was four times greater than that for alpha 1-adrenergic receptors. Scatchard analysis revealed that SPE significantly reduced the maximal number of binding sites (Bmax) for each radioligand in the prostate and bladder under in vitro condition. Repeated oral administration of SPE to rats brought about significant alteration in Bmax for prostatic [3H]prazosin binding and for bladder [3H]NMS binding. Such alteration by SPE was selective to the receptors in the lower urinary tract.
CONCLUSIONS: Saw palmetto extract exerts significant binding activity on autonomic receptors in the lower urinary tract under in vitro and in vivo conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17572227     DOI: 10.1016/j.urology.2007.02.038

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

Review 1.  Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia.

Authors:  Youngjoo Kwon
Journal:  Food Sci Biotechnol       Date:  2019-04-17       Impact factor: 2.391

Review 2.  Pharmacological effects of saw palmetto extract in the lower urinary tract.

Authors:  Mayumi Suzuki; Yoshihiko Ito; Tomomi Fujino; Masayuki Abe; Keizo Umegaki; Satomi Onoue; Hiroshi Noguchi; Shizuo Yamada
Journal:  Acta Pharmacol Sin       Date:  2009-03       Impact factor: 6.150

3.  Saw palmetto ethanol extract inhibits adipocyte differentiation.

Authors:  Nicole Villaverde; Adriana Galvis; Adriana Marcano; Horacio A Priestap; Bradley C Bennett; M Alejandro Barbieri
Journal:  J Nat Med       Date:  2012-11-23       Impact factor: 2.343

4.  A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency.

Authors:  H V Sudeep; Jestin V Thomas; K Shyamprasad
Journal:  BMC Urol       Date:  2020-07-03       Impact factor: 2.264

Review 5.  WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH.

Authors:  Ruth Kirschner-Hermanns; Petra Funk; Nadine Leistner
Journal:  Ther Adv Urol       Date:  2019-10-11

6.  Beneficial Effects of Saw Palmetto Fruit Extract on Urinary Symptoms in Japanese Female Subjects by a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Shizuo Yamada; Michiyo Shirai; Ken Ono; Shinji Kageyama
Journal:  Nutrients       Date:  2022-03-11       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.